Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-04-22

Clinical Trial Update: Effect of Methyl-Sulphonyl-Methane on Osteoarthritis and Cartilage [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effects of Methyl-Sulphonyl-Methane on osteoarthritis and cartilage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methyl-Sulphonyl-Methane (methylsulphonylmethane)

Snippet

Sponsor: G.Papanikolaou Research Group | Conditions: Osteoarthritis | Phase 1 | Status: UNKNOWN